Michael Clarke

Michael Clarke is a Senior Honorary Research Fellow at the School of Biomedical Sciences, University of Western Australia. He holds roles as Director of Scientific Services at ChemCentre (Western Australia) and was former Node Leader of Metabolomics Australia. His research focuses on metabolomics, vitamin D metabolism, drug pharmacokinetics, and method development in mass spectrometry.

Research Interests: Clarke’s work spans metabolomics in diverse sample types, vitamin D’s role in health outcomes, and drug efficacy in animal models. He pioneered a reference assay for serum vitamin D analysis and leads projects on cardiovascular nutrition and antioxidant mechanisms. His lab is CDC-certified for vitamin D analysis and collaborates on marine, plant, and biomedical studies using advanced mass spectrometry techniques.

Articles Trends: Recent work emphasizes vitamin D’s impact on diseases like multiple sclerosis and abdominal aortic aneurysm, alongside metabolomic studies in marine organisms and fetal pharmacokinetics. His research bridges clinical, environmental, and veterinary applications of metabolic profiling.

Awards & Grants: Clarke has secured $5M+ in funding from NCRIS, Bioplatforms Australia, and the Rural Industries Research & Development Corporation. Notable projects include vitamin D’s role in MS, honeybee product development, and gut biodiversity studies. No specific awards are listed, but his work is recognized via 78+ publications and collaborations worldwide.

Advising & Labs: He manages the Biological and Molecular Mass Spectrometry facility at UWA and contributed to teaching clinical biochemistry at Curtin University. Equipment includes Agilent mass spectrometers and GCMS systems, supporting metabolomics and proteomics research. Current projects include the D-Light initiative on early immune development.